Literature DB >> 21720855

Effects of obstetric factors and storage temperatures on the yield of endothelial colony forming cells from umbilical cord blood.

Kate E Coldwell1, Stephanie J Lee, Jennifer Kean, Cheen P Khoo, Grigorios Tsaknakis, Jon Smythe, Suzanne M Watt.   

Abstract

As umbilical cord blood (UCB) is a rich source of endothelial colony-forming cells (ECFC), our aim was twofold: (1) to examine potential obstetric selection criteria for achieving the highest ECFC yields from UCB units, and (2) to determine whether transient storage temperatures of fresh UCB and cryopreservation of UCB units affected ECFC yield and function. ECFC quality was assessed before and after cryopreservation by their clonogenic proliferative potential. Of the 20 factors examined, placental weight was the only statistically significant obstetric factor that predicted ECFC frequency in UCB. Studies on the effects of storage revealed that transient storage of fresh UCB at 4°C reduced ECFC yield compared with storage at 22°C, while cryopreservation of UCB MNCs significantly reduced ECFC recoveries. To our knowledge, this is the first demonstration that placental weight and temperature of storage prior to processing or culture have significant effects on ECFC frequency in UCB. Our studies further support the evidence that cryopreservation of UCB MNCs compromises ECFC recovery.

Entities:  

Mesh:

Year:  2011        PMID: 21720855      PMCID: PMC3155043          DOI: 10.1007/s10456-011-9222-4

Source DB:  PubMed          Journal:  Angiogenesis        ISSN: 0969-6970            Impact factor:   9.596


  34 in total

1.  Origins of circulating endothelial cells and endothelial outgrowth from blood.

Authors:  Y Lin; D J Weisdorf; A Solovey; R P Hebbel
Journal:  J Clin Invest       Date:  2000-01       Impact factor: 14.808

2.  Optimizing donor selection in a cord blood bank.

Authors:  Pilar Solves; Alfredo Perales; Vicente Mirabet; Ignacio Blasco; Amando Blanquer; D Planelles; Luis Larrea; Javier Monleon; F Carbonell-Uberos; M Angeles Soler
Journal:  Eur J Haematol       Date:  2004-02       Impact factor: 2.997

3.  Differential in vivo potential of endothelial progenitor cells from human umbilical cord blood and adult peripheral blood to form functional long-lasting vessels.

Authors:  Patrick Au; Laurence M Daheron; Dan G Duda; Kenneth S Cohen; James A Tyrrell; Ryan M Lanning; Dai Fukumura; David T Scadden; Rakesh K Jain
Journal:  Blood       Date:  2007-11-09       Impact factor: 22.113

Review 4.  Human endothelial stem/progenitor cells, angiogenic factors and vascular repair.

Authors:  Suzanne M Watt; Athanasios Athanassopoulos; Adrian L Harris; Grigorios Tsaknakis
Journal:  J R Soc Interface       Date:  2010-09-15       Impact factor: 4.118

5.  Birthweight of full-term infants is associated with cord blood CD34+ cell concentration.

Authors:  P Aroviita; K Teramo; V Hiilesmaa; P Westman; R Kekomäki
Journal:  Acta Paediatr       Date:  2004-10       Impact factor: 2.299

6.  Human umbilical cord blood as a potential source of transplantable hematopoietic stem/progenitor cells.

Authors:  H E Broxmeyer; G W Douglas; G Hangoc; S Cooper; J Bard; D English; M Arny; L Thomas; E A Boyse
Journal:  Proc Natl Acad Sci U S A       Date:  1989-05       Impact factor: 11.205

7.  The London Cord Blood Bank: analysis of banking and transplantation outcome.

Authors:  Sue Davey; Sue Armitage; Vanderson Rocha; Federico Garnier; Juliette Brown; Colin J Brown; Ruth Warwick; Deidre Fehily; Suzanne Watt; Eliane Gluckman; Ajay Vora; Marcela Contreras; Cristina V Navarrete
Journal:  Br J Haematol       Date:  2004-05       Impact factor: 6.998

8.  In vitro hyperglycemia or a diabetic intrauterine environment reduces neonatal endothelial colony-forming cell numbers and function.

Authors:  David A Ingram; Izlin Z Lien; Laura E Mead; Myka Estes; Daniel N Prater; Ethel Derr-Yellin; Linda A DiMeglio; Laura S Haneline
Journal:  Diabetes       Date:  2007-12-17       Impact factor: 9.461

Review 9.  Cryopreservation of hematopoietic stem/progenitor cells for therapeutic use.

Authors:  Suzanne M Watt; Eric Austin; Sue Armitage
Journal:  Methods Mol Biol       Date:  2007

Review 10.  Umbilical cord blood transplantation: the first 20 years.

Authors:  John E Wagner; Eliane Gluckman
Journal:  Semin Hematol       Date:  2010-01       Impact factor: 3.851

View more
  5 in total

1.  Isolation of functional human endothelial cells from small volumes of umbilical cord blood.

Authors:  Sa Do Kang; Tim A Carlon; Alexandra E Jantzen; Fu-Hsiung Lin; Melissa M Ley; Jason D Allen; Thomas V Stabler; N Rebecca Haley; George A Truskey; Hardean E Achneck
Journal:  Ann Biomed Eng       Date:  2013-04-19       Impact factor: 3.934

2.  Association between maternal and fetal factors and quality of cord blood as a source of stem cells.

Authors:  Rodrigo Dias Nunes; Flávia Maria Zandavalli
Journal:  Rev Bras Hematol Hemoter       Date:  2014-11-26

Review 3.  Could cord blood cell therapy reduce preterm brain injury?

Authors:  Jingang Li; Courtney A McDonald; Michael C Fahey; Graham Jenkin; Suzanne L Miller
Journal:  Front Neurol       Date:  2014-10-09       Impact factor: 4.003

4.  miR-193a-3p interaction with HMGB1 downregulates human endothelial cell proliferation and migration.

Authors:  Cheen P Khoo; Maria G Roubelakis; Jack B Schrader; Grigorios Tsaknakis; Rebecca Konietzny; Benedikt Kessler; Adrian L Harris; Suzanne M Watt
Journal:  Sci Rep       Date:  2017-03-09       Impact factor: 4.379

5.  Spindle shaped human mesenchymal stem/stromal cells from amniotic fluid promote neovascularization.

Authors:  Maria G Roubelakis; Grigorios Tsaknakis; Kalliopi I Pappa; Nicholas P Anagnou; Suzanne M Watt
Journal:  PLoS One       Date:  2013-01-24       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.